Longhua Sun

机构：Nanchang University · ORCID：0000-0002-2891-1477

发表论文 78 篇 · 总被引 1646 次 · h-index 23

代表论文

• Sacituzumab tirumotecan versus docetaxel for previously treated EGFR -mutated advanced non-small cell lung cancer: multicentre, open label, randomised controlled trial (2025 · BMJ · 被引 41)
• Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial (2025 · The Lancet · 被引 33)
• Interplay between acetylation and ubiquitination controls PSAT1 protein stability in lung adenocarcinoma (2024 · Communications Biology · 被引 18)
• Sacituzumab tirumotecan (sac-TMT) in patients (pts) with previously treated advanced EGFR-mutated non-small cell lung cancer (NSCLC): Results from the randomized OptiTROP-Lung03 study. (2025 · Journal of Clinical Oncology · 被引 10)
• Potent covalent irreversible inhibitor of KRAS G12C IBI351 in patients with advanced solid tumors: First-in-human phase I study (2024 · European Journal of Cancer · 被引 10)
• Characterization of a novel RNAi yeast insecticide that silences mosquito 5-HT1 receptor genes (2023 · Scientific Reports · 被引 9)